James H. McConnell

Specialty / focus. James H. McConnell is a patent litigator whose practice centers on infringement cases in U.S. district courts and the International Trade Commission. Firm-published descriptions place his technology coverage across pharmaceuticals and life sciences, computer hardware/software, smartphones and wireless communications, and medical devices, with experience across the full lifecycle (pre-suit analysis, claim construction, summary judgment, trial, and ITC enforcement). He is also described as handling patent portfolio analysis, pre-litigation strategy, and IP due diligence.

Side preference. The single tracked appearance is defendant-side: McConnell appeared pro hac vice for Teva Pharmaceuticals USA and Actavis Elizabeth in Novartis Pharmaceuticals Corp. v. Teva Pharmaceuticals USA, Inc. (D. Del., No. 1:18-cv-01039), a Hatch-Waxman pharmaceutical patent suit. That is a narrow basis (1 defendant-side matter, 0 plaintiff matters), but his firm bios state he represents both clients asserting and clients defending against patent infringement, so the one-sided tracked docket likely understates a mixed practice.

Firm context and notable matters. He was an intellectual property partner in Kirkland & Ellis's New York office (where the tracked Novartis v. Teva appearance occurred) before joining Fox Rothschild LLP in New York as counsel in the Intellectual Property Department in July 2024. The tracked Novartis v. Teva matter is the only specific case I can verify from the authoritative data; I could not locate a verifiable disposition or appellate outcome for it, and no other headline verdicts or Federal Circuit results were confirmed in available sources.

PTAB / bar / education. I found no reliable evidence of regular PTAB/IPR practice, so that should be treated as unverified rather than confirmed. Bar and education are reliably sourced: admitted in New York (2011); J.D., Cornell Law School (2010); B.A., Hamilton College (2007). Note that several lawyers share the "James McConnell" name; the details above were confirmed against the Kirkland/New York profile and the July 2024 Fox Rothschild announcement, which match this attorney's credentials and practice description.